WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry, tax reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| GEORGE OLSEN | — |
Health Issues HCR
21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in Continuing Resolution and Consolidated Appropriations Act, 2016; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee chronic disease initiative; Implementation of Precision Medicine Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
| ANTHONY J RODA | — |
Medicare/Medicaid MMM
Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Independent Payment Advisory Board (IPAB).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| CHERYL LYNN JAEGER | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.